Although much work is being done to develop new treatments, research and knowledge regarding factors underlying implant-related microbial colonization leading to infection are less comprehensive. Presence of microorganisms in and around implants clinically characterized as uninfected remains unknown. The objective of this study was to detect and identify bacteria and fungi on implants from various groups of patients with no prior indications of implant related infections. Patient samples (implants and tissue) were collected from five different hospitals in the Capital region of Denmark. By in-depth microbiological detection methods, we examined the prevalence of bacteria and fungi on 106 clinically uninfected implants from four patient groups (aseptic loosening, healed fractures, craniofacial complications and recently deceased). Of 106 clinically uninfected implants and 39 negative controls investigated, 66% were colonized by bacteria and 40% were colonized by fungi (p < 0.0001 compared to negative controls). A large number of microbes were found to colonize the implants, however, the most prevalent microbes present were not common aetiological agents of implant infections. The findings indicate that implants provide a distinct niche for microbial colonization. These data have broad implications for medical implant recipients, as well as for supporting the idea that the presence of foreign objects in the body alters the human microbiome by providing new colonization niches.
*Joint first author.
Implants are an important part of modern medicine, saving thousands of people from impaired mobility, morbidity and mortality (1) . Based on medical progress in this area along with new implant technologies, future decades are expected to see an increase in~600% in total knee revisions between 2005 and 2030 in the US (2) . The primary complication (20-25%) following implant surgery is colonization of the implant surface or adjacent tissue with microorganisms that can ultimately necessitate implant removal and replacement (3) . Dependant on the location of the implant and the surgical procedure, infection rates average between 1 and 2% (4, 5) .
A key aspect of chronic implant infections is that they are caused by aggregates of bacteria, known as biofilms. Biofilms are well-known to be recalcitrant to both host defence and antibiotics and have been proposed as a critical contributor to chronic infections. Indeed, recent evidence suggests that biofilms with diameters smaller than 100 lm (less than~10 5 bacteria) are capable of sustaining a chronic bacterial infection, although these infections may initially be asymptomatic for the patient (6) . The small numbers of bacteria comprising an aggregate makes it difficult to detect by conventional clinical microbiology techniques (7) , but modern PCR-based methods increase the potentials (8) (9) (10) . The lack of symptoms may not prompt investigation of infection, however, such infections can trigger low-level inflammation, which builds over time and ultimately leads to symptoms (11) . Based on these observations, we hypothesized that apparently uninfected implants (hereafter designated 'clinically uninfected') may harbour microbial communities. To test this hypothesis, we used microbiological and molecular techniques to examine clinically uninfected implants that had been removed for reasons other than clinical or paraclinical indication of infection, for the presence of microbial communities including negative controls (devises temporarily inserted into patients during primary knee operation and deceased as well as devises opened in surgery room and laboratory).
MATERIALS AND METHODS

Study design
The study is a non-interventional exploratory clinical study. Patient samples (implants and tissue) were collected from five different hospitals in the Capital Region of Denmark (Region Hovedstaden, RH) between February 5, 2013, and April 4, 2017. In total 106 clinically uninfected implants were removed from four different groups of patients: those with aseptic loosening, healed fractures, craniofacial complications and recently deceased. Five implants that had been deemed clinically infected were used as positive controls. Thirty-nine negative controls, described in detail below, were also included. The inclusion criterion was the presence of an implant. Except for positive controls exclusion criteria were signs of putrefaction or inflammation and/or a history of infection of the implant.
The following information was obtained from each patient: age, gender, body mass index (BMI), implant age, implant type, known diseases, current medicine, history of infection, immune status as well as tobacco and alcohol use. Limited information (BMI, implant type, age and gender) was available for 18 individuals in the recently deceased group. No information was available for the patients in the craniofacial implant group or from three individuals from the aseptic implant group and the positive control group (Table 1) .
By combining results from different patient groups makes this study the first of its kind with no prior experimental results to base a power analysis for calculation of a necessary sample size. As for the negative controls based on our findings of colonization of approximately 70% of the 106 implants and assuming that 35% of the negative controls to be colonized we estimated that 40 controls will allow us to detect a significantly lower background with a power of 0.95 and a p-value below 1%. For the immunological investigations the investigators were blinded. The study was approved by the National and regional ethical committee of Copenhagen, Denmark (1500093 and H-2-2012-144 (46596)).
Sample collection
All surgical procedures were performed using standard aseptic techniques. Implants were surgically removed, placed in a sterile container (Lock&Lock, Anaheim, CA, USA) and covered by sterile physiological saline (Substrate Department, Panum, Copenhagen, Denmark (SD)). Implants from deceased individuals were retrieved within 48 h post-mortem and only if the body had been kept at 4°C (12) . For the aseptic loosening group, tissue adjacent to the implant was excised and split into two sections. One section was preserved in 4% buffered formaldehyde (VWR, Radnor, Pennsylvania, USA), while the other was preserved in RNAlater (Life Technologies, Waltham, MA, USA).
All subsequent handling of materials or samples was performed in a laminar flow cabinet. All materials used for sample handling and for DNA purification were UV sterilized within a closed laminar flow bench for at least 30 min before use. For DNA isolation and microbe culturing, all implants were sonicated for 5 min then vortexed for 30 s as previously described (13) . The sonication liquid was centrifuged at 7500 g for 20 min until the pellet could be re-suspended in a maximum of 2 mL of physiological saline (SD). The resulting suspension was used for DNA purification and streak plating on LuriaBertani agar plates, modified Conradi-Drigalski ("blue") agar plates and Blood agar plates (Statens Serum institute (SSI), Copenhagen, Denmark). Plates were incubated for 48 h at 37°C, and identification of the cultured microbes was performed using Matrix-Assisted Laser Desorption/ Ionization-Time of Flight (MALDI-TOF) spectroscopy (Bruker, Bremen, Germany).
Negative controls
A total of 39 negative control implants were included in the study to assess the false positive rate. These included: (i) 11 implant screws that were placed into wound during primary knee surgery before removal; (ii) 10 implants screws that were implanted into deceased individuals during post-mortem examination. For implantation, the area of incision was washed with iodine solution, then an incision was made through the skin with a sterile scalpel. Further incision to reach the bone was made with a new disposable sterile scalpel. The screws were placed touching the bone for approximately 20 s before removed; (iii) two implants (knee spacers) were unpacked in a surgery room and; (iv) 16 implants were unpacked in the laboratory. All the implant materials were stored at 4°C in sterile physiological saline (SD) until tested for microbial contamination by the same DNA purification, PCR and sequencing methods (described below) as used for the test implants.
Histopathology
Tissue samples were prepared and stained as previously described (14) . One tissue section from each sample was stained with haematoxylin and eosin and analysed by one observer (AGG) with medical background and 6 years of forensic pathology experience and by a specialist and experienced pathologist (HPH), to assess the infiltration of inflammatory cells. The degree of inflammation was determined for each sample as none, mild, moderate or severe infiltration of inflammatory cells. Histological analysis was performed using a Leica light microscope equipped with polarization filters and an integrated eyepiece graticule.
DNA purification, PCR and sequencing DNA was purified from tissue samples (25 mg) and pellet from sonicated/vortexed implants using the QIAamp (Qiagen, Hilden, Germany) tissue kit according to the manufacturer's instructions, with a slight modification: tissues were incubated overnight with proteinase K rather than for 4 h. Real-time polymerase chain reactions were performed using universal fungal and bacterial primers. Samples with a cycle threshold (C t ) value of ≥2 cycles lower than the C t value of the NTC and Tm value similar to that of the positive controls (AE5°C) were considered positive. A cut-off of 2 or 1 cycles from the NTC to consider samples positive has been used by others (15) (16) (17) . Amplicons from positive samples were purified using the GFX PCR Purification Kit (Amersham; GE Healthcare, Amersham, UK) and sequenced by Macrogen Europe (Macrogen, Amsterdam, The Netherlands). The resulting sequences were analysed using BLAST (http://blast.ncbi. nlm.nih.gov) and LeBIBI (https://umr5558-bibiserv.univlyon1.fr/lebibi/lebibi.cgi). When possible, polymicrobial samples were analysed using the RipSeq algorithm (Pathogenomix, Santa Cruz, CA, USA) to separate the sequences (18) .
The forward (5 0 -YAACGAGCGCAACCC-3 0 ) (14) and reverse (5 0 -AGGCCCGGGAACGYATTYAACG-3 0 ) (14) bacterial primers (Y=C or T) were designed to anneal to 16S rDNA, while the fungal primers were designed to anneal to the ITS86 (5 0 -GTGAATCATCGAATCTTT-GAAC-3 0 ) and ITS4 (5 0 -TCCTCCGCTTATTGATATGC-3 0 ) regions on the 5.8S rDNA, respectively (19) . The primers were synthesized by TAG (Copenhagen, Denmark To determine the sensitivity of our molecular detection method (DNA extraction, PCR and subsequent sequencing) we spiked non-infected tissue with a dilution series ranging from 10 0 to 10 7 of P. aeruginosa, Staphylococcus aureus and C. albicans. We were not able to identify less than 10 4 of either P. aeruginosa, S. aureus or C. albicans with our experimental methods.
Statistical analysis
Potential differences between implant infections sites were investigated by comparing the two dominant implant groups, screws and knees to the rest of the implants were performed with Fisher's exact tests using Prism 6 (GraphPad, La Jolla, CA, USA). A p value ≤ 0.05 was considered significant. Power calculation was based on comparison of the findings of either bacterial or fungal DNA content in the 106 patient samples with the 39 sterile samples using Sampsize at http://sampsize.sourceforge. net/cgi-bin/s1.cgi.
RESULTS
Study population
To examine whether presumably 'sterile' implants harboured microbial communities, we examined 106 implants along with surrounding tissue from 105 individuals. These implants were removed from recently deceased persons who died of non-infectionrelated causes (n = 46) and from clinical noninfected patients, i.e., aseptic loosening (n = 20), craniofacial implants (n = 20) or fracture healing (n = 20). Five implants from patients with known infection were included as positive controls. As false positives are a key concern in studies such as this, 39 negative controls were included. These negative controls included implants directly removed from packaging that had been introduced into surgical wounds of living and deceased individuals. The craniofacial implant group and three individuals of the aseptic implant group were not included in our patient characteristic due to lack of information. Of the remaining 82 individuals, 48 were male (59%), the median age was 64 (18-97) years, the BMI was 25 (13.5-40.1) and the implant residence time was 13 months (1 day-432 months). An overview of the patient characteristics is presented in Table 1 .
Foreign bodies initiates a new niche for a microbiota to arise
Of the 106 clinically uninfected implants (Table S1 ) examined, 70 (66%) were positive for bacteria, 43 (40%) were positive for fungi, and 78 (73%) were positive for either bacteria, fungi or both (Table 2 ). An implant was categorized as positive for microorganisms when a tissue sample, implant sonicate or both where positive for microorganisms since the microorganisms in the tissue where considered to be associated with the implant. The microbes detected appeared to be specific for their respective implant groups (Fig. 1) . Implants removed due to healed fractures appeared to be colonized primarily by microbes usually associated with the skin and mucosal membranes, whereas implants removed due to aseptic loosening were colonized primarily by microbes associated with mucosal membranes. Implants from the deceased group were mainly colonized by microbes originating from mucosal membranes and the intestinal flora. Finally, bacteria and fungi colonizing implants from the craniofacial group were associated with the skin, mucosal membranes and the oral cavity. Fig. 1 provides an overview of the genera and species of bacteria and fungi identified.
When comparing PCR and culturing methods, a higher number of fungi were detected with PCR, whereas the bacterial number detected and identified by culturing and PCR were more similar (Table 3) . To investigate any potential difference in implant type, the two dominant groups of implants, screws and knees (Table S1) , were compared with the remaining implants. There was a significant difference in the number of positive bacterial findings between the groups. For the screws there was a significantly higher number of positives compared to the rest of the implants (p = 0.033) while the knees had a significantly lower number of positives compared to the rest of the implants (p = 0.0082) (Fishers Exact test on a 2 by 2 table). No difference was seen when comparing frequency of fungal colonization of implant types. In the five implants used as positive controls, bacteria well known to cause implant infections were identified. As controls for contamination during sample processing, 39 sterile implant materials were tested for the presence of either bacterial or fungal DNA content. Twenty of the control implants were inserted in patients and the remaining included packages that were either opened during surgery or in the laboratory. Since all control implants tested negative after being processed similar to the investigated implants from patients (Table S2) the frequency of findings of either bacterial or fungal DNA were lower on the negative control implants than the patient samples (p < 0.0001; power > 99%) indicating that contamination during sample processing was not of significant concern in this study.
Age, BMI, implant age, medical history or the general health of study participants were not confounding factors when analysing patient history and positive microbial findings of the clinically uninfected implants. None of the participants had a history or symptoms suggestive of bacteraemia or fungaemia after the implant had been inserted. There was no correlation between the post-mortem interval (PMI), the time from death to autopsy and positive findings for either bacteria or fungi in test or control samples.
Low infiltration of inflammatory cells despite presence of microorganisms
Although it is clear from our findings that clinically uninfected implants are colonized with microbes, it was not clear whether the presence of these microbes caused an inflammatory reaction. To test this, we performed a histopathological analysis of the tissue surrounding the implant. This analysis revealed that none of the samples obtained from recently deceased patients showed any signs of infiltration by inflammatory cells, whereas 90% of the healed fracture and craniofacial implants had mild to moderate infiltration. Of the 99 tissue samples The total number of positive samples (positive for either bacteria, fungi or both). 2 Percentage of identified species (incl. polyfungal and polybacterial) of the number of positive bacteria and fungi in each group. 3 No culturing results for the deceased group and positive control group. 4 Only qPCR (detection) and not sequencing (identification) results were available for the craniofacial group. 
DISCUSSION
This study aimed to determine whether 'clinically uninfected' implants (implants not removed because of infection) harboured microbes. We examined implants and associated tissue from individuals with no history, clinical or paraclinical signs of implant infection. Based on the current diagnostic criteria for prosthetic joint infections (PJIs) (4) none of the subjects included in this study would be categorized as having an active implant infection. The histopathological evaluation of the adjacent tissue of the included implants showed no or little inflammatory infiltration which supports the lack of active infection.
Although most of the bacteria and fungi identified in the present study have previously been identified as aetiological agents of implant infections (20) (21) (22) , none of the most common bacteria or fungi (e.g., Staphylococcus epidermidis, S. aureus, Propionibacterium acnes and P. aeruginosa) were found. An interesting observation was that significantly more screws were found to be colonized compared to other implants. The screws are often localized close to the skin and in direct contact with both the implant and the bone which provides several opportunities for microbial colonization. Our findings are consistent with studies that have investigated supposedly aseptic cases of revision arthroplasty and detected bacteria by using PCR technology (8, 23) . To our knowledge this is the first study to have examined post-mortem implants with regard to microbial colonization of presumably uninfected implants. Postmortem microbiology is used in limited cases, primarily in the explanation of Sudden Unexplained Death Syndrome (SUDI) and Sudden Infant Death Syndrome (SIDS), causes of septic shock and in forensic microbiology (12, (24) (25) (26) (27) . The presence of contaminating bacteria is possible when working post-mortem, but has been shown to most likely be due to contamination induced by the forensic staff or post-mortem microbial transmigration (12) . In addition, it was shown that there is no significant increase in the number of positive findings as the PMI to sampling increase. It is generally accepted that samples taken before 48 h post-mortem will yield results of acceptable quality if kept at 4°C (12) .
Sample contamination is a potential problem but the procedures used to prevent sample contamination such as standard aseptic surgery techniques alleviate this problem (28, 29) . To elucidate whether the detected microorganisms were truly inhabiting the implants of the present study, we analysed 39 different sterile implant materials that had undergone different handling procedures identical to those used in this study. All control samples were negative for bacteria and fungi, thus we are confident that our findings are not contamination. Our detection limit determined in vitro was 10 4 microorganisms thus we cannot rule out the presence of microbes below this level.
One question our study raises is why the microbiology of symptomatic infected implants are different from the microbiome of uninfected implants. We hypothesize that when sterile implants are inserted a new niche is created for the "implant microbiota" to colonize. In the event of infection with a conventional pathogen, the implant microbiota may be eradicated or displaced by the newly arrived pathogen or the pathogen-induced inflammatory response. This could explain why we do not find the usual implant associated microorganisms and why the microorganisms we find are not usually associated with PJI.
Our findings have several implications. Firstly, they challenge guidelines and methods regarding diagnosis of infections on implants because it opens the possibility that bacteria and fungi might play a part in what has hitherto been determined as noninfection-related problems such as aseptic loosening or fracture healing. Secondly, and with somewhat contrary implications, the findings suggests that certain type of bacteria and fungi can be present on or adjacent to implants seemingly without clinical symptoms. Thus, the study not only provides important methodological discussions on how we diagnose infections, but simultaneously calls for more analytical discussions on the very definition of infections and the role of bacteria present in human tissue around implants. Due to the absence of inflammatory cells our study also propose that the insertion of foreign bodies initiates a new niche for a microbiota to arise generating a potential implant microbiome, thus creating additional novel symbiotic microbiomes within our body.
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